SanBio Co Ltd (SNBIF)
3.85
0.00 (0.00%)
USD |
OTCM |
Nov 15, 16:00
SanBio EPS Diluted (Quarterly): -0.108 for July 31, 2024
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2024 | -0.108 |
| April 30, 2024 | -0.014 |
| January 31, 2024 | -0.0785 |
| October 31, 2023 | -0.0099 |
| July 31, 2023 | -0.1281 |
| April 30, 2023 | -0.0726 |
| January 31, 2023 | -0.4795 |
| October 31, 2022 | 0.0471 |
| July 31, 2022 | -0.2503 |
| April 30, 2022 | -0.0499 |
| January 31, 2022 | -0.2641 |
| October 31, 2021 | -0.1707 |
| July 31, 2021 | -0.2239 |
| April 30, 2021 | -0.1542 |
| January 31, 2021 | 0.2704 |
| October 31, 2020 | -0.2988 |
| July 31, 2020 | -0.3062 |
| April 30, 2020 | -0.2683 |
| January 31, 2020 | -0.3339 |
| October 31, 2019 | -0.2224 |
| Date | Value |
|---|---|
| July 31, 2019 | -0.2375 |
| April 30, 2019 | -0.1333 |
| January 31, 2019 | -0.251 |
| October 31, 2018 | -0.0912 |
| July 31, 2018 | -0.0372 |
| April 30, 2018 | -0.1707 |
| January 31, 2018 | -0.1529 |
| October 31, 2017 | -0.1746 |
| July 31, 2017 | -0.2326 |
| April 30, 2017 | -0.2162 |
| January 31, 2017 | -0.0281 |
| October 31, 2016 | -0.1187 |
| July 31, 2016 | -0.1825 |
| April 30, 2016 | -0.0552 |
| January 31, 2016 | -0.0976 |
| October 31, 2015 | -0.0057 |
| July 31, 2015 | -0.0624 |
| April 30, 2015 | -0.0223 |
| January 31, 2015 | -0.04 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.4795
Minimum
Jan 2023
0.2704
Maximum
Jan 2021
-0.1523
Average
-0.1542
Median
Apr 2021
EPS Diluted (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 0.1924 |
| Nxera Pharma Co Ltd | 0.0906 |
| PeptiDream Inc | 0.9276 |
| Healios KK | -0.038 |
| AnGes Inc | -0.1057 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.409M |
| Total Expenses (Quarterly) | 5.761M |
| Enterprise Value | 247.52M |
| Earnings Yield | -5.47% |
| Normalized Earnings Yield | -24.04 |